FIELD: medicine.
SUBSTANCE: invention refers to medicine and veterinary science. A method provides using bacterial 7P ribonuclease for increasing the effectiveness of suppression of RNA- and DNA-containing virus replication for treating acute viral diseases in mammals and warm-blooded animals.
EFFECT: Bacillus intermedius RNAase suppression of virus replication is ensured by using substantially lower doses of enzymes introduced into an infected body with the increased effectiveness of virus replication and therapeutic process.
2 cl, 8 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING IMMOBILIZED NUCLEASES | 0 |
|
SU730690A1 |
| ANTI-RABIS MEDICATION | 2009 |
|
RU2420309C2 |
| STREPTOMYCIN-RESISTANT STRAIN Bacillus sp ARCIM B-9862, PRODUCER OF EXTRACELLULAR ALKALINE RIBONUCLEASE | 2008 |
|
RU2384619C1 |
| ANTIVIRAL AGENT BASED ON SERRATIA-FAMILY BACTERIA NUCLEASE | 2014 |
|
RU2580242C2 |
| AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
| USE OF ENZYME OF RIBONUCLEASE Bacillus pumilus AS INHIBITOR OF PHYTOPATHOGENIC VIRUS | 2013 |
|
RU2542480C1 |
| MEDICATION, POSSESSING ANTIOXIDANT, CARDIOPROTECTIVE, ANTIDIABETIC, ANTI -INFLAMMATORY, HEPATOPROTECTIVE, ANTITUMORAL AND ANTIVIRAL ACTION | 2010 |
|
RU2432959C1 |
| 0 |
|
SU1781295A1 | |
| Aeromonas bestiarum BACTERIA STRAIN - PRODUCER OF ALKALINE RIBONUCLEASE HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2520086C1 |
| STRAIN OF BACTERIA Serratia plymuthica HAVING ANTIVIRAL ACTIVITY AGAINST INFLUENZA VIRUS OF TYPE A (VERSIONS) | 2013 |
|
RU2551316C1 |
